BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 21191681)

  • 1. Nonalcoholic fatty liver disease in India - a lot done, yet more required!
    Duseja A
    Indian J Gastroenterol; 2010 Nov; 29(6):217-25. PubMed ID: 21191681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease in India--is it different?
    Duseja A
    Trop Gastroenterol; 2006; 27(4):142-6. PubMed ID: 17542290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
    Farrell GC; Larter CZ
    Hepatology; 2006 Feb; 43(2 Suppl 1):S99-S112. PubMed ID: 16447287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload in nonalcoholic steatohepatitis.
    Fujita N; Takei Y
    Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West.
    Duseja A; Das A; Das R; Dhiman RK; Chawla Y; Bhansali A; Kalra N
    Dig Dis Sci; 2007 Sep; 52(9):2368-74. PubMed ID: 17420951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.
    Kim CH; Younossi ZM
    Cleve Clin J Med; 2008 Oct; 75(10):721-8. PubMed ID: 18939388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; MiezyƄska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and diagnosis of NAFLD/NASH.
    Hashimoto E; Taniai M; Tokushige K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Massoud O; Charlton M
    Clin Liver Dis; 2018 Feb; 22(1):201-211. PubMed ID: 29128057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research.
    Patton HM; Sirlin C; Behling C; Middleton M; Schwimmer JB; Lavine JE
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):413-27. PubMed ID: 17033514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease.
    Radwan MM; Radwan BM; Nandipati KC; Hunter WJ; Agrawal DK
    Expert Rev Clin Immunol; 2013 Aug; 9(8):727-38. PubMed ID: 23971751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground.
    Chitturi S; Wong VW; Farrell G
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():163-72. PubMed ID: 21199528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment.
    Smith BW; Adams LA
    Nat Rev Endocrinol; 2011 May; 7(8):456-65. PubMed ID: 21556019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-alcoholic steatohepatitis - from NAFLD to MAFLD].
    Balmer ML; Dufour JF
    Ther Umsch; 2011 Apr; 68(4):183-8. PubMed ID: 21452138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH).
    Ota T
    Adv Exp Med Biol; 2021; 1261():223-229. PubMed ID: 33783745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.
    Duseja A; Singh SP; Saraswat VA; Acharya SK; Chawla YK; Chowdhury S; Dhiman RK; Jayakumar RV; Madan K; Misra SP; Mishra H; Modi SK; Muruganathan A; Saboo B; Sahay R; Upadhyay R
    J Clin Exp Hepatol; 2015 Mar; 5(1):51-68. PubMed ID: 25941433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.